Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Vfend Injectable

This product is the most expensive of its product family


Contraindicated
Reproductive toxicity in animals

Contraindicated
Vfend Injectable :
Type Medicine Authorised
Originator B
Agent Droguerie Fattal
Distributor Droguerie Fattal
Laboratory Pfizer
Responsible Party Pfizer Europe MA EEIG
Origin Belgium
Manufacturer Fareva
Origin France
ATC J02AC03

Your comment will appear shortly after approval

Vfend Injectable :

Revision Date : 23/06/2014


Effect Frequency
Abdominal pain Very Common
Acute kidney injury Common
Acute respiratory distress syndrome Common
Adrenal insufficiency Uncommon
Agitation Common
Agranulocytosis Common
Alanine aminotransferase abnormal Not known
Alopecia Common
Anaemia Common
Anaphylactoid reactions Uncommon
Angioedema (Angioneurotic oedema) (Quincke oedema) Uncommon
Anxiety Common
Arrhythmia Not known
Arrhythmia supraventricular Common
Arthritis Uncommon
AST abnormal Not known
Asthenia Common
Ataxia Uncommon
Atrioventricular block complete Rare
Back pain Common
Blepharitis Uncommon
Blood alkaline phosphatase abnormal Not known
Blood bilirubin abnormal Not known
Blood bilirubin increased Not known
Blood cholesterol increased Uncommon
Blood creatinine increased Common
Blood lactate dehydrogenase abnormal Not known
Blood urea increased Uncommon
Bone marrow failure Uncommon
Bradycardia Common
Bundle branch block Rare
Cerebral oedema (Brain oedema) Uncommon
Cheilitis Common
Chest pain Common
Chills Common
Cholecystitis Uncommon
Cholelithiasis (Calculus biliary) (Gallstones) Uncommon
Chromatopsia Very Common
Confusional state Common
Constipation Common
Corneal opacity Rare
Cutaneous lupus erythematosus Not known
Depression Common
Dermatitis allergic Uncommon
Dermatitis exfoliative Common
Diarrhoea (Diarrhea) Very Common
Diplopia Uncommon
Disseminated intravascular coagulation Uncommon
Dizziness Common
Duodenitis Uncommon
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Uncommon
Dyspepsia Common
ECG QT prolonged Uncommon
Eczema Uncommon
Encephalopathy Uncommon
Eosinophilia Uncommon
Erythema Common
Erythema multiforme Uncommon
Extrapyramidal disorder Uncommon
Face oedema Common
Fixed drug eruption Rare
Gamma-GT abnormal Not known
Gastroenteritis Common
Gingivitis Common
Glossitis Uncommon
Guillain-Barre syndrome Rare
Haematuria (Hematuria) Common
Hallucination Common
Headache Very Common
Hepatic encephalopathy Rare
Hepatic enzyme increased Not known
Hepatic failure (Hepatic insufficiency) (Liver failure) Uncommon
Hepatitis Common
Hepatomegaly Uncommon
Hepatotoxicity (liver toxicity) Not known
Hypersensitivity Common
Hyperthyroidism Rare
Hypertonia Common
Hypoacusis Uncommon
Hypoesthesia Uncommon
Hypoglycaemia Common
Hypokalaemia Common
Hyponatraemia (Hyponatremia) Common
Hypotension Common
Hypothyroidism Uncommon
Influenza-like illness Common
Injection site reaction Uncommon
Insomnia Common
Jaundice Common
Jaundice cholestatic (Cholestatic icterus) Common
Leucopenia (Leukopenia) Uncommon
Liver function test abnormal Very Common
Lyell Syndrome (Toxic epidermal necrolysis) Uncommon
Lymphadenopathy Uncommon
Lymphangitis Uncommon
Maculopapular rash Common
Nausea Very Common
Nephritis Uncommon
Neuropathy peripheral Uncommon
Nodal rhythm Rare
Nystagmus Uncommon
Oculogyric crisis Uncommon
Oedema peripheral Very Common
Optic atrophy Rare
Optic nerve disorder Uncommon
Optic neuritis Uncommon
Pancreatitis Uncommon
Pancytopenia Common
Papilloedema Uncommon
Paraesthesia (paresthesia) Common
Periostitis Not known
Peritonitis Uncommon
Phlebitis Common
Photophobia Very Common
Photosensitivity reaction Common
Proteinuria Uncommon
Pruritus Common
Pseudomembranous colitis Uncommon
Pseudoporphyria Rare
Psoriasis Uncommon
Pulmonary oedema Common
Purpura Uncommon
Pyrexia Very Common
Rash macular Uncommon
Rash papular Uncommon
Renal tubular necrosis Uncommon
Respiratory distress Very Common
Retinal haemorrhage Common
Retinogram abnormal Not known
scleritis Uncommon
Seizures Common
Sinusitis Common
Skin rash Very Common
Somnolence Common
Squamous cell carcinoma of skin Not known
Stevens-Johnson syndrome Uncommon
Supraventricular tachycardia Uncommon
Swollen tongue Uncommon
Syncope Common
Tachycardia Common
Thrombocytopenia (Thrombopenia) Common
Thrombophlebitis Uncommon
Tinnitus Uncommon
Torsade de pointes Rare
Tremor Common
Urticaria Uncommon
Ventricular extrasystoles Uncommon
Ventricular fibrillation Uncommon
Ventricular tachycardia Uncommon
Vertigo Uncommon
Vision blurred Very Common
Visual disturbance Very Common
Vomiting Very Common

Different Units By MoH Code

Revision Date : 06/05/2022

Revision Date : 06/05/2022

Vfend Injectable  MoH 10525 :
Form Powder for solution for infusion
Packaging Vial (Type I Glass)
Package Size Box of 1
Package Content 30 ml clear Type I glass vial with rubber stopper and aluminium cap with plastic seal
Strength 200mg
Public Price 9834773.19 L.L.
Stratum C
NSSF ✔
Quarantine ✘
Reg. Number 168249/10
Submission date 2021
Registration Year 04/05/2021


NB : Reregistration in 2021 with same manufacturer

Price Comparison

● Country: Finland
● Package Size: 1
● Public Price: 256.54 EUR ( 24,852,569.04 LBP )
● Pack size unit used: 1
● Cost/Unit: 256,54 EUR ( 24,800,256.00 LBP )
● Reference: Kela
● Pricing Date: 22/04/2021
● Type: Medicine Authorised

● Country: Denmark
● Package Size: 1
● Public Price: 1770.9 DKK ( 22,979,198.40 LBP )
● Pack size unit used: 1
● Cost/Unit: 1770,9 DKK ( 22,967,520.00 LBP )
● Pharmacy Price: 1311.59 DKK ( 17019191.84 LBP )
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Authorised

● Country: Switzerland
● Package Size: 1
● Public Price: 207.15 CHF ( 21,423,453.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 207,15 CHF ( 21,407,940.00 LBP )
● Exfactory Price: 166.18 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

● Country: Germany
● Package Size: 1
● Public Price: 203.02 EUR ( 19,667,765.52 LBP )
● Pack size unit used: 1
● Cost/Unit: 203,02 EUR ( 19,665,828.00 LBP )
● Pricing Date: 24/10/2020
● Type: Medicine Authorised

● Country: Italy
● Package Size: 1
● Public Price: 185.52 EUR ( 17,972,435.52 LBP )
● Pack size unit used: 1
● Cost/Unit: 185,52 EUR ( 17,922,060.00 LBP )
● Exfactory Price: 112.4 EUR
● Pricing Date: 17/12/2019
● Type: Medicine Authorised

● Country: Spain
● Package Size: 1 vial
● Public Price: 164.64 EUR ( 15,949,664.64 LBP )
● Pack size unit used: 1
● Cost/Unit: 164,64 EUR ( 15,887,664.00 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Authorised

● Country: Iceland
● Package Size: 1
● Public Price: 24166 ISK ( 15,587,070.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 24166 ISK ( 15,587,070.00 LBP )
● Pharmacy Price: 16495 ISK ( 10639275 LBP )
● Reference: Icelandic Medicines Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Qatar
● Package Size: 1
● Public Price: 566 QAR ( 13,899,828.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 566 QAR ( 13,899,828.00 LBP )
● Pharmacy Price: 464.46392993 QAR ( 11406305.191221 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

● Country: Kuweit
● Package Size: Boîte de 1
● Public Price: 46.39 KWD ( 13,619,222.59 LBP )
● Pack size unit used: 1
● Cost/Unit: 46,39 KWD ( 13,504,726.00 LBP )
● Pharmacy Price: 39.19 KWD ( 11505439.39 LBP )
● Pricing Date: 07/02/2021
● Type: Medicine Authorised

● Country: Cyprus
● Package Size: 1
● Public Price: 139.22 EUR ( 13,487,076.72 LBP )
● Pack size unit used: 1
● Cost/Unit: 139,22 EUR ( 13,465,764.00 LBP )
● Reference: Cyprus Minister of Health
● Pricing Date: 24/03/2021
● Type: Medicine Authorised

● Country: Oman
● Package Size: 1
● Public Price: 58.34 OMR ( 13,461,021.56 LBP )
● Pack size unit used: 1
● Cost/Unit: 58,34 OMR ( 13,382,572.00 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 1 Vial
● Public Price: 544 AED ( 13,143,584.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 544 AED ( 13,143,584.00 LBP )
● Pharmacy Price: 450.12 AED ( 10875349.32 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 1
● Public Price: 544 AED ( 13,143,584.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 544 AED ( 13,143,584.00 LBP )
● Pharmacy Price: 450.12 AED ( 10875349.32 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: Czech Republic
● Package Size: 1+1x50ml
● Public Price: 3350.13 CZK ( 12,794,146.47 LBP )
● Pack size unit used: 1
● Cost/Unit: 3350,13 CZK ( 12,793,650.00 LBP )
● Reference: SUKL
● Pricing Date: 28/02/2020
● Type: Medicine Authorised

● Country: Bahrain
● Package Size: 1
● Public Price: 50.26 BHD ( 11,948,510.84 LBP )
● Pack size unit used: 1
● Cost/Unit: 50,26 BHD ( 11,886,700.00 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021
● Type: Medicine Authorised

● Country: KSA
● Package Size: 1
● Public Price: 483.9 SAR ( 11,439,396.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 483,9 SAR ( 11,418,120.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Lebanon
● Form: Powder for solution for infusion
● Package Size: Box of 1
● Public Price: 9834773.19 LBP ( 9,834,773.19 LBP )
● Pack size unit used: 1
● Cost/Unit: 9834773,19 LBP ( 9,834,773.00 LBP )
● Pricing Date: 13/06/2024

● Country: Sweden
● Package Size: 1
● Public Price: 1167.23 SEK ( 9,814,069.84 LBP )
● Pack size unit used: 1
● Cost/Unit: 1167,23 SEK ( 9,812,136.00 LBP )
● Pharmacy Price: 1099 SEK ( 9240392 LBP )
● Pricing Date: 23/04/2020
● Type: Medicine Authorised

● Country: UK
● Package Size: 1
● Public Price: 77.14 GBP ( 8,766,883.86 LBP )
● Pack size unit used: 1
● Cost/Unit: 77,14 GBP ( 8,750,973.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Norway
● Package Size: 1
● Public Price: 1077.8 NOK ( 8,734,491.20 LBP )
● Pack size unit used: 1
● Cost/Unit: 1077,8 NOK ( 8,728,008.00 LBP )
● Pharmacy Price: 816.93 NOK ( 6620400.72 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Greece
● Package Size: 1
● Public Price: 89.97 EUR ( 8,715,933.72 LBP )
● Pack size unit used: 1
● Cost/Unit: 89,97 EUR ( 8,621,964.00 LBP )
● Exfactory Price: 67.43 EUR
● Pharmacy Price: 70.73 EUR ( 6852039.48 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/03/2019
● Type: Medicine Non Marketed

● Country: Jordan
● Package Size: 1
● Public Price: 57.3 JOD ( 7,175,163.30 LBP )
● Pack size unit used: 1
● Cost/Unit: 57,3 JOD ( 7,137,597.00 LBP )
● Pharmacy Price: 55.1 JOD ( 6899677.1 LBP )
● Reference: JFDA
● Pricing Date: 02/01/2021
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 1
● Public Price: 67 EUR ( 6,490,692.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 67 EUR ( 6,490,692.00 LBP )
● Reference: cbip
● Pricing Date: 02/12/2020
● Type: Medicine Authorised

● Country: Egypt
● Package Size: Boîte de 1
● Public Price: 630 EGP ( 1,149,750.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 630 EGP ( 1,149,750.00 LBP )
● Pricing Date: 02/12/2019
● Type: Medicine Authorised

● Country: Turkey
● Package Size: 1
● Public Price: 290.75 TRY ( 779,210.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 290,75 TRY ( 777,200.00 LBP )
● Pricing Date: 28/10/2020
● Type: Medicine Authorised

● Country: France
● Package Size: 1
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 256,54 EUR ( 24,800,256.00 LBP )
● Cost/Day: 513,08 EUR ( 49,697,388.00 LBP )
● Cost/Month: 3591,56 EUR ( 347,881,716.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 256,54 EUR ( 24,800,256.00 LBP )
● Cost/Day: 513,08 EUR ( 49,697,388.00 LBP )
● Cost/Month: 3591,56 EUR ( 347,881,716.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 256,54 EUR ( 24,800,256.00 LBP )
● Cost/Day: 513,08 EUR ( 49,697,388.00 LBP )
● Cost/Month: 3591,56 EUR ( 347,881,716.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 256,54 EUR ( 24,800,256.00 LBP )
● Cost/Day: 513,08 EUR ( 49,697,388.00 LBP )
● Cost/Month: 3591,56 EUR ( 347,881,716.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 1770,9 DKK ( 22,967,520.00 LBP )
● Cost/Day: 3541,8 DKK ( 45,948,016.00 LBP )
● Cost/Month: 24792,6 DKK ( 321,700,992.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 1770,9 DKK ( 22,967,520.00 LBP )
● Cost/Day: 3541,8 DKK ( 45,948,016.00 LBP )
● Cost/Month: 24792,6 DKK ( 321,700,992.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 1770,9 DKK ( 22,967,520.00 LBP )
● Cost/Day: 3541,8 DKK ( 45,948,016.00 LBP )
● Cost/Month: 24792,6 DKK ( 321,700,992.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 1770,9 DKK ( 22,967,520.00 LBP )
● Cost/Day: 3541,8 DKK ( 45,948,016.00 LBP )
● Cost/Month: 24792,6 DKK ( 321,700,992.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 207,15 CHF ( 21,407,940.00 LBP )
● Cost/Day: 414,3 CHF ( 42,815,880.00 LBP )
● Cost/Month: 2900,1 CHF ( 299,918,000.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 207,15 CHF ( 21,407,940.00 LBP )
● Cost/Day: 414,3 CHF ( 42,815,880.00 LBP )
● Cost/Month: 2900,1 CHF ( 299,918,000.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 207,15 CHF ( 21,407,940.00 LBP )
● Cost/Day: 414,3 CHF ( 42,815,880.00 LBP )
● Cost/Month: 2900,1 CHF ( 299,918,000.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 207,15 CHF ( 21,407,940.00 LBP )
● Cost/Day: 414,3 CHF ( 42,815,880.00 LBP )
● Cost/Month: 2900,1 CHF ( 299,918,000.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 203,02 EUR ( 19,665,828.00 LBP )
● Cost/Day: 406,04 EUR ( 39,331,656.00 LBP )
● Cost/Month: 2842,28 EUR ( 275,321,592.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 203,02 EUR ( 19,665,828.00 LBP )
● Cost/Day: 406,04 EUR ( 39,331,656.00 LBP )
● Cost/Month: 2842,28 EUR ( 275,321,592.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 203,02 EUR ( 19,665,828.00 LBP )
● Cost/Day: 406,04 EUR ( 39,331,656.00 LBP )
● Cost/Month: 2842,28 EUR ( 275,321,592.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 203,02 EUR ( 19,665,828.00 LBP )
● Cost/Day: 406,04 EUR ( 39,331,656.00 LBP )
● Cost/Month: 2842,28 EUR ( 275,321,592.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 185,52 EUR ( 17,922,060.00 LBP )
● Cost/Day: 371,04 EUR ( 35,940,996.00 LBP )
● Cost/Month: 2597,28 EUR ( 251,586,972.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 185,52 EUR ( 17,922,060.00 LBP )
● Cost/Day: 371,04 EUR ( 35,940,996.00 LBP )
● Cost/Month: 2597,28 EUR ( 251,586,972.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 185,52 EUR ( 17,922,060.00 LBP )
● Cost/Day: 371,04 EUR ( 35,940,996.00 LBP )
● Cost/Month: 2597,28 EUR ( 251,586,972.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 185,52 EUR ( 17,922,060.00 LBP )
● Cost/Day: 371,04 EUR ( 35,940,996.00 LBP )
● Cost/Month: 2597,28 EUR ( 251,586,972.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 164,64 EUR ( 15,887,664.00 LBP )
● Cost/Day: 329,28 EUR ( 31,872,204.00 LBP )
● Cost/Month: 2304,96 EUR ( 223,202,304.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 164,64 EUR ( 15,887,664.00 LBP )
● Cost/Day: 329,28 EUR ( 31,872,204.00 LBP )
● Cost/Month: 2304,96 EUR ( 223,202,304.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 164,64 EUR ( 15,887,664.00 LBP )
● Cost/Day: 329,28 EUR ( 31,872,204.00 LBP )
● Cost/Month: 2304,96 EUR ( 223,202,304.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 164,64 EUR ( 15,887,664.00 LBP )
● Cost/Day: 329,28 EUR ( 31,872,204.00 LBP )
● Cost/Month: 2304,96 EUR ( 223,202,304.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 24166 ISK ( 15,587,070.00 LBP )
● Cost/Day: 48332 ISK ( 31,174,140.00 LBP )
● Cost/Month: 338324 ISK ( 218,218,980.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 24166 ISK ( 15,587,070.00 LBP )
● Cost/Day: 48332 ISK ( 31,174,140.00 LBP )
● Cost/Month: 338324 ISK ( 218,218,980.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 24166 ISK ( 15,587,070.00 LBP )
● Cost/Day: 48332 ISK ( 31,174,140.00 LBP )
● Cost/Month: 338324 ISK ( 218,218,980.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 24166 ISK ( 15,587,070.00 LBP )
● Cost/Day: 48332 ISK ( 31,174,140.00 LBP )
● Cost/Month: 338324 ISK ( 218,218,980.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 566 QAR ( 13,899,828.00 LBP )
● Cost/Day: 1132 QAR ( 27,799,656.00 LBP )
● Cost/Month: 7924 QAR ( 194,597,592.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 566 QAR ( 13,899,828.00 LBP )
● Cost/Day: 1132 QAR ( 27,799,656.00 LBP )
● Cost/Month: 7924 QAR ( 194,597,592.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 566 QAR ( 13,899,828.00 LBP )
● Cost/Day: 1132 QAR ( 27,799,656.00 LBP )
● Cost/Month: 7924 QAR ( 194,597,592.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 566 QAR ( 13,899,828.00 LBP )
● Cost/Day: 1132 QAR ( 27,799,656.00 LBP )
● Cost/Month: 7924 QAR ( 194,597,592.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 46,39 KWD ( 13,504,726.00 LBP )
● Cost/Day: 92,78 KWD ( 27,009,452.00 LBP )
● Cost/Month: 649,46 KWD ( 190,534,069.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 46,39 KWD ( 13,504,726.00 LBP )
● Cost/Day: 92,78 KWD ( 27,009,452.00 LBP )
● Cost/Month: 649,46 KWD ( 190,534,069.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 46,39 KWD ( 13,504,726.00 LBP )
● Cost/Day: 92,78 KWD ( 27,009,452.00 LBP )
● Cost/Month: 649,46 KWD ( 190,534,069.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 46,39 KWD ( 13,504,726.00 LBP )
● Cost/Day: 92,78 KWD ( 27,009,452.00 LBP )
● Cost/Month: 649,46 KWD ( 190,534,069.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 139,22 EUR ( 13,465,764.00 LBP )
● Cost/Day: 278,44 EUR ( 26,931,528.00 LBP )
● Cost/Month: 1949,08 EUR ( 188,811,324.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 139,22 EUR ( 13,465,764.00 LBP )
● Cost/Day: 278,44 EUR ( 26,931,528.00 LBP )
● Cost/Month: 1949,08 EUR ( 188,811,324.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 139,22 EUR ( 13,465,764.00 LBP )
● Cost/Day: 278,44 EUR ( 26,931,528.00 LBP )
● Cost/Month: 1949,08 EUR ( 188,811,324.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 139,22 EUR ( 13,465,764.00 LBP )
● Cost/Day: 278,44 EUR ( 26,931,528.00 LBP )
● Cost/Month: 1949,08 EUR ( 188,811,324.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 58,34 OMR ( 13,382,572.00 LBP )
● Cost/Day: 116,68 OMR ( 26,765,144.00 LBP )
● Cost/Month: 816,76 OMR ( 188,278,944.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 58,34 OMR ( 13,382,572.00 LBP )
● Cost/Day: 116,68 OMR ( 26,765,144.00 LBP )
● Cost/Month: 816,76 OMR ( 188,278,944.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 58,34 OMR ( 13,382,572.00 LBP )
● Cost/Day: 116,68 OMR ( 26,765,144.00 LBP )
● Cost/Month: 816,76 OMR ( 188,278,944.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 58,34 OMR ( 13,382,572.00 LBP )
● Cost/Day: 116,68 OMR ( 26,765,144.00 LBP )
● Cost/Month: 816,76 OMR ( 188,278,944.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 544 AED ( 13,143,584.00 LBP )
● Cost/Day: 1088 AED ( 26,287,168.00 LBP )
● Cost/Month: 7616 AED ( 184,010,176.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 544 AED ( 13,143,584.00 LBP )
● Cost/Day: 1088 AED ( 26,287,168.00 LBP )
● Cost/Month: 7616 AED ( 184,010,176.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 544 AED ( 13,143,584.00 LBP )
● Cost/Day: 1088 AED ( 26,287,168.00 LBP )
● Cost/Month: 7616 AED ( 184,010,176.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 544 AED ( 13,143,584.00 LBP )
● Cost/Day: 1088 AED ( 26,287,168.00 LBP )
● Cost/Month: 7616 AED ( 184,010,176.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 544 AED ( 13,143,584.00 LBP )
● Cost/Day: 1088 AED ( 26,287,168.00 LBP )
● Cost/Month: 7616 AED ( 184,010,176.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 544 AED ( 13,143,584.00 LBP )
● Cost/Day: 1088 AED ( 26,287,168.00 LBP )
● Cost/Month: 7616 AED ( 184,010,176.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 544 AED ( 13,143,584.00 LBP )
● Cost/Day: 1088 AED ( 26,287,168.00 LBP )
● Cost/Month: 7616 AED ( 184,010,176.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 544 AED ( 13,143,584.00 LBP )
● Cost/Day: 1088 AED ( 26,287,168.00 LBP )
● Cost/Month: 7616 AED ( 184,010,176.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 3350,13 CZK ( 12,793,650.00 LBP )
● Cost/Day: 6700,26 CZK ( 25,587,300.00 LBP )
● Cost/Month: 46901,82 CZK ( 179,114,919.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 3350,13 CZK ( 12,793,650.00 LBP )
● Cost/Day: 6700,26 CZK ( 25,587,300.00 LBP )
● Cost/Month: 46901,82 CZK ( 179,114,919.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 3350,13 CZK ( 12,793,650.00 LBP )
● Cost/Day: 6700,26 CZK ( 25,587,300.00 LBP )
● Cost/Month: 46901,82 CZK ( 179,114,919.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 3350,13 CZK ( 12,793,650.00 LBP )
● Cost/Day: 6700,26 CZK ( 25,587,300.00 LBP )
● Cost/Month: 46901,82 CZK ( 179,114,919.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 50,26 BHD ( 11,886,700.00 LBP )
● Cost/Day: 100,52 BHD ( 23,773,400.00 LBP )
● Cost/Month: 703,64 BHD ( 167,127,002.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 50,26 BHD ( 11,886,700.00 LBP )
● Cost/Day: 100,52 BHD ( 23,773,400.00 LBP )
● Cost/Month: 703,64 BHD ( 167,127,002.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 50,26 BHD ( 11,886,700.00 LBP )
● Cost/Day: 100,52 BHD ( 23,773,400.00 LBP )
● Cost/Month: 703,64 BHD ( 167,127,002.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 50,26 BHD ( 11,886,700.00 LBP )
● Cost/Day: 100,52 BHD ( 23,773,400.00 LBP )
● Cost/Month: 703,64 BHD ( 167,127,002.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 483,9 SAR ( 11,418,120.00 LBP )
● Cost/Day: 967,8 SAR ( 22,859,880.00 LBP )
● Cost/Month: 6774,6 SAR ( 160,137,360.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 483,9 SAR ( 11,418,120.00 LBP )
● Cost/Day: 967,8 SAR ( 22,859,880.00 LBP )
● Cost/Month: 6774,6 SAR ( 160,137,360.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 483,9 SAR ( 11,418,120.00 LBP )
● Cost/Day: 967,8 SAR ( 22,859,880.00 LBP )
● Cost/Month: 6774,6 SAR ( 160,137,360.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 483,9 SAR ( 11,418,120.00 LBP )
● Cost/Day: 967,8 SAR ( 22,859,880.00 LBP )
● Cost/Month: 6774,6 SAR ( 160,137,360.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 9834773,19 LBP ( 9,834,773.00 LBP )
● Cost/Day: 19669546,38 LBP ( 19,669,546.00 LBP )
● Cost/Month: 137686824,66 LBP ( 137,686,824.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 9834773,19 LBP ( 9,834,773.00 LBP )
● Cost/Day: 19669546,38 LBP ( 19,669,546.00 LBP )
● Cost/Month: 137686824,66 LBP ( 137,686,824.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 9834773,19 LBP ( 9,834,773.00 LBP )
● Cost/Day: 19669546,38 LBP ( 19,669,546.00 LBP )
● Cost/Month: 137686824,66 LBP ( 137,686,824.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 9834773,19 LBP ( 9,834,773.00 LBP )
● Cost/Day: 19669546,38 LBP ( 19,669,546.00 LBP )
● Cost/Month: 137686824,66 LBP ( 137,686,824.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 1167,23 SEK ( 9,812,136.00 LBP )
● Cost/Day: 2334,46 SEK ( 19,624,272.00 LBP )
● Cost/Month: 16341,22 SEK ( 137,395,128.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 1167,23 SEK ( 9,812,136.00 LBP )
● Cost/Day: 2334,46 SEK ( 19,624,272.00 LBP )
● Cost/Month: 16341,22 SEK ( 137,395,128.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 1167,23 SEK ( 9,812,136.00 LBP )
● Cost/Day: 2334,46 SEK ( 19,624,272.00 LBP )
● Cost/Month: 16341,22 SEK ( 137,395,128.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 1167,23 SEK ( 9,812,136.00 LBP )
● Cost/Day: 2334,46 SEK ( 19,624,272.00 LBP )
● Cost/Month: 16341,22 SEK ( 137,395,128.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 77,14 GBP ( 8,750,973.00 LBP )
● Cost/Day: 154,28 GBP ( 17,501,946.00 LBP )
● Cost/Month: 1079,96 GBP ( 122,627,271.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 77,14 GBP ( 8,750,973.00 LBP )
● Cost/Day: 154,28 GBP ( 17,501,946.00 LBP )
● Cost/Month: 1079,96 GBP ( 122,627,271.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 77,14 GBP ( 8,750,973.00 LBP )
● Cost/Day: 154,28 GBP ( 17,501,946.00 LBP )
● Cost/Month: 1079,96 GBP ( 122,627,271.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 77,14 GBP ( 8,750,973.00 LBP )
● Cost/Day: 154,28 GBP ( 17,501,946.00 LBP )
● Cost/Month: 1079,96 GBP ( 122,627,271.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 1077,8 NOK ( 8,728,008.00 LBP )
● Cost/Day: 2155,6 NOK ( 17,464,120.00 LBP )
● Cost/Month: 15089,2 NOK ( 122,281,256.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 1077,8 NOK ( 8,728,008.00 LBP )
● Cost/Day: 2155,6 NOK ( 17,464,120.00 LBP )
● Cost/Month: 15089,2 NOK ( 122,281,256.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 1077,8 NOK ( 8,728,008.00 LBP )
● Cost/Day: 2155,6 NOK ( 17,464,120.00 LBP )
● Cost/Month: 15089,2 NOK ( 122,281,256.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 1077,8 NOK ( 8,728,008.00 LBP )
● Cost/Day: 2155,6 NOK ( 17,464,120.00 LBP )
● Cost/Month: 15089,2 NOK ( 122,281,256.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 89,97 EUR ( 8,621,964.00 LBP )
● Cost/Day: 179,94 EUR ( 17,340,804.00 LBP )
● Cost/Month: 1259,58 EUR ( 121,966,884.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 89,97 EUR ( 8,621,964.00 LBP )
● Cost/Day: 179,94 EUR ( 17,340,804.00 LBP )
● Cost/Month: 1259,58 EUR ( 121,966,884.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 89,97 EUR ( 8,621,964.00 LBP )
● Cost/Day: 179,94 EUR ( 17,340,804.00 LBP )
● Cost/Month: 1259,58 EUR ( 121,966,884.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 89,97 EUR ( 8,621,964.00 LBP )
● Cost/Day: 179,94 EUR ( 17,340,804.00 LBP )
● Cost/Month: 1259,58 EUR ( 121,966,884.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 57,3 JOD ( 7,137,597.00 LBP )
● Cost/Day: 114,6 JOD ( 14,275,194.00 LBP )
● Cost/Month: 802,2 JOD ( 100,427,242.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 57,3 JOD ( 7,137,597.00 LBP )
● Cost/Day: 114,6 JOD ( 14,275,194.00 LBP )
● Cost/Month: 802,2 JOD ( 100,427,242.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 57,3 JOD ( 7,137,597.00 LBP )
● Cost/Day: 114,6 JOD ( 14,275,194.00 LBP )
● Cost/Month: 802,2 JOD ( 100,427,242.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 57,3 JOD ( 7,137,597.00 LBP )
● Cost/Day: 114,6 JOD ( 14,275,194.00 LBP )
● Cost/Month: 802,2 JOD ( 100,427,242.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 67 EUR ( 6,490,692.00 LBP )
● Cost/Day: 134 EUR ( 12,981,384.00 LBP )
● Cost/Month: 938 EUR ( 90,869,688.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 67 EUR ( 6,490,692.00 LBP )
● Cost/Day: 134 EUR ( 12,981,384.00 LBP )
● Cost/Month: 938 EUR ( 90,869,688.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 67 EUR ( 6,490,692.00 LBP )
● Cost/Day: 134 EUR ( 12,981,384.00 LBP )
● Cost/Month: 938 EUR ( 90,869,688.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 67 EUR ( 6,490,692.00 LBP )
● Cost/Day: 134 EUR ( 12,981,384.00 LBP )
● Cost/Month: 938 EUR ( 90,869,688.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 630 EGP ( 1,149,750.00 LBP )
● Cost/Day: 1260 EGP ( 2,299,500.00 LBP )
● Cost/Month: 8820 EGP ( 16,096,500.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 630 EGP ( 1,149,750.00 LBP )
● Cost/Day: 1260 EGP ( 2,299,500.00 LBP )
● Cost/Month: 8820 EGP ( 16,096,500.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 630 EGP ( 1,149,750.00 LBP )
● Cost/Day: 1260 EGP ( 2,299,500.00 LBP )
● Cost/Month: 8820 EGP ( 16,096,500.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 630 EGP ( 1,149,750.00 LBP )
● Cost/Day: 1260 EGP ( 2,299,500.00 LBP )
● Cost/Month: 8820 EGP ( 16,096,500.00 LBP )
Candidemia in non-neutropenic patients : (Adults)
● Cost/Unit: 290,75 TRY ( 777,200.00 LBP )
● Cost/Day: 581,5 TRY ( 1,557,080.00 LBP )
● Cost/Month: 4070,5 TRY ( 10,907,600.00 LBP )
Invasive aspergillosis : (Adults)
● Cost/Unit: 290,75 TRY ( 777,200.00 LBP )
● Cost/Day: 581,5 TRY ( 1,557,080.00 LBP )
● Cost/Month: 4070,5 TRY ( 10,907,600.00 LBP )
Invasive candidiasis : (Adults)
● Cost/Unit: 290,75 TRY ( 777,200.00 LBP )
● Cost/Day: 581,5 TRY ( 1,557,080.00 LBP )
● Cost/Month: 4070,5 TRY ( 10,907,600.00 LBP )
Serious fungal infections caused by Scedosporium spp. And Fusarium spp. : (Adults)
● Cost/Unit: 290,75 TRY ( 777,200.00 LBP )
● Cost/Day: 581,5 TRY ( 1,557,080.00 LBP )
● Cost/Month: 4070,5 TRY ( 10,907,600.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info